Cargando…
Salivary MicroRNA in Pancreatic Cancer Patients
BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer death in Western countries, with the lowest 1-year survival rate among commonly diagnosed cancers. Reliable biomarkers for pancreatic cancer diagnosis are lacking and are urgently needed to allow for curative surgery. As microRNA (m...
Autores principales: | Humeau, Marine, Vignolle-Vidoni, Alix, Sicard, Flavie, Martins, Frédéric, Bournet, Barbara, Buscail, Louis, Torrisani, Jérôme, Cordelier, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486170/ https://www.ncbi.nlm.nih.gov/pubmed/26121640 http://dx.doi.org/10.1371/journal.pone.0130996 |
Ejemplares similares
-
Molecular Endoscopic Ultrasound for Diagnosis of Pancreatic Cancer
por: Bournet, Barbara, et al.
Publicado: (2011) -
Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis
por: Delpu, Yannick, et al.
Publicado: (2011) -
The Rescue of miR-148a Expression in Pancreatic Cancer: An Inappropriate Therapeutic Tool
por: Delpu, Yannick, et al.
Publicado: (2013) -
Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas
por: Bournet, Barbara, et al.
Publicado: (2016) -
Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes
por: Rouanet, Marie, et al.
Publicado: (2017)